PFNLive
- Stocks Mixed as Major Companies Report Earnings
- Severe U.S. Flu Season Helps Reckitt Top Forecasts
- Sanofi Infant Vaccine gets EU Approval
- Stock Futures up with Full Earnings Calendar on Tap
- TiGenix Reports Positive Phase IIa Results in Arthritis
- Elan Board Unanimously Rejects Royalty Pharma Bid
- Takeda in More Trouble at Home over Recall of Mislabeled Vials
- Nasdaq Extends Gain, up 1 Percent on Tech Results
- Civitas Parkinson's Drug Improves Motor Fluctuations in Phase II Trial
- Astellas, GSK Vie to Make 'High Altitude' Anaemia Pill
- Intuitive Surgical Narrows 2013 Forecast, Shares Fall
- Wall Street Set to Rebound after Breaching Key Level
- Vertex Gains as Cystic Fibrosis Combo Eases Breathing
- Johnson & Johnson Cashes out on Elan Shares after Failed Alzheimer's Trials
- Bayer, Amgen Face Price Cuts as German Panel Expands Drug Review
- Stocks Move Lower on Wall Street; eBay Slides
- Baxter Posts Lower Earnings on Acquisition-Related Expenses
- UnitedHealth First-Quarter Profit Slips as Medical Costs Rise
- Wall Street Set for Modest Bounce After Claims Data, Earnings
- GlaxoSmithKline Picks up FDA Panel Plug for Breo Approval
